Phase 2: HZBio1 12mg — clinical trials using this drug

Public-registry trials using Phase 2: HZBio1 12mg that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.

Trial	Sponsor	Condition	Phase	Sites
Study of Safety, PK, and Efficacy of Multiple Ascending Doses of HZBio1 in Patients With Gout	Hangzhou Grand Biologic Pharmaceutical, Inc.	Gout	PHASE1 / PHASE2	1

Free site-risk snapshot for any of these trials

Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →